Raphas Co., Ltd. (KOSDAQ:214260)

Market Cap	113.60B
Revenue (ttm)	28.85B
Net Income (ttm)	-7.84B
Shares Out	8.41M
EPS (ttm)	-906.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,186
Average Volume	25,036
Open	13,440
Previous Close	13,320
Day's Range	13,440 - 13,690
52-Week Range	12,500 - 22,150
Beta	1.16
RSI	34.21
Earnings Date	Nov 14, 2025

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was founded in 2006 and is headquartered in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 79
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2024, Raphas's revenue was 27.22 billion, a decrease of -2.58% compared to the previous year's 27.94 billion. Losses were -4.77 billion, -45.80% less than in 2023.